Healthcare -
Biotechnology - NASDAQ - US
$ 2.6
4 %
$ 358 M
Market Cap
-7.43
P/E
CMPX - CAPITAL EXPENDITURES
Capital Expenditures CMPX - Compass Therapeutics, Inc.
-30 K
LAST VALUE
86.17%
2 YEAR CAGR
56.91%
5 YEAR CAGR
0.00%
10 YEAR CAGR